Streetbeat News

Revenues

ARDX

Ardelyx (NASDAQ: ARDX) reported Q2 2024 GAAP EPS of $(0.07), beating the $(0.10) estimate. Sales were $73.222M, surpassing the $55.019M estimate and showing a significant year-over-year increase.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 8:23 pm

SPT

Sprout Social has released its Q3 financial guidance, projecting adjusted EPS of $0.12-$0.13, slightly above the consensus estimate of $0.12. The company also expects total revenue to be between $101.9 million and $102.1 million, marginally higher than the estimated $101.89 million.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 8:23 pm

MMSI

Merit Medical Systems (NASDAQ:MMSI) reported Q2 2024 earnings per share of $0.92, surpassing the analyst estimate of $0.87. The company also reported sales of $338.00 million, exceeding the estimate of $334.55 million. This represents a 5.61% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 8:23 pm

ACA

Arcosa (NYSE:ACA) reported Q2 2024 adjusted EPS of $0.91, beating the $0.83 estimate and showing a 19.74% increase from last year. Sales were $664.7M, surpassing the $661.54M estimate and marking a 13.66% year-over-year increase.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 8:23 pm

PCOR

Procore Technologies (NYSE:PCOR) reported strong Q2 earnings, with adjusted EPS of $0.39 beating the $0.25 estimate and sales of $284.35M surpassing the $275.25M estimate. This represents a significant year-over-year growth in both earnings and sales.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 8:22 pm

REFR

Research Frontiers (NASDAQ:REFR) reported Q2 sales of $489.59K, marking a 164.59% increase from $185.04K YoY.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 8:22 pm

X

United States Steel (NYSE:X) reported Q2 2024 adjusted EPS of $0.84, beating the $0.77 estimate. Sales were $4.12 billion, surpassing the $4.02 billion estimate but down 17.77% from last year's $5.01 billion.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 8:22 pm

VIR

Vir Biotechnology (NASDAQ:VIR) reported Q2 2024 adjusted EPS of $(1.02), missing the $(0.90) estimate by 13.33%. Sales were $3.10M, missing the $7.50M estimate by 58.65% and down 18.36% from last year's $3.80M.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 8:21 pm

VTR

Ventas (NYSE: VTR) reported Q2 2024 earnings per share (EPS) of $0.80, surpassing the analyst consensus estimate of $0.79. The company also reported quarterly sales of $1.20 billion, exceeding the estimate of $1.19 billion. This represents an 8.59% increase over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 8:21 pm

HASI

Hannon Armstrong (NYSE:HASI) reported Q2 earnings of $0.63 per share, beating the analyst estimate of $0.57. However, sales of $62.78 million missed the $71.55 million estimate.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 8:21 pm